Viewing Study NCT04852861


Ignite Creation Date: 2025-12-24 @ 12:36 PM
Ignite Modification Date: 2026-01-31 @ 3:57 PM
Study NCT ID: NCT04852861
Status: COMPLETED
Last Update Posted: 2023-03-28
First Post: 2021-04-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: COVID-19: Safety and Immunogenicity of a Reduced Dose of the BioNTech/Pfizer BNT162b2 Vaccine
Sponsor: Sciensano
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Covid19 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None vaccination View
None Covid19 View
None immunogenicity View